Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation
Zu‐Guo Zheng(China Pharmaceutical University), Xiaojun Xu(The Fourth People's Hospital), Yaping Zhou(China Pharmaceutical University), Zhishen Xie(First Affiliated Hospital of Henan University), Pyone Myat Thu(China Pharmaceutical University), Chong Lu(China Pharmaceutical University), Daqian Xu(Zhejiang University), Xin Zhang(Academy of Military Medical Sciences), Hui‐Jun Li(China Pharmaceutical University), Yan Chen(Zhengzhou University), Bin Xue(China Pharmaceutical University), Xiaowei Chen(Peking University), Tao Pang(China Pharmaceutical University)
Cited by 38
Related Papers
Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity
|Nature Communications|2019|252
Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy
|Current Medicinal Chemistry|2015|201
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
|Nature Medicine|2017|187